Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway

[1]  L. Iversen,et al.  Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophilsin vitro. Evidence of formation of antiinflammatory compounds , 1991, Agents and Actions.

[2]  C. Serhan.  Lipoxins: Eicosanoids carrying intra-and intercellular messages , 1991, Journal of bioenergetics and biomembranes.

[3]  M. Brezinski,et al.  Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Serhan.  On the relationship between leukotriene and lipoxin production by human neutrophils: evidence for differential metabolism of 15-HETE and 5-HETE. , 1989, Biochimica et biophysica acta.

[5]  K. Kragballe,et al.  Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. , 1989, The Journal of investigative dermatology.

[6]  K. Kragballe,et al.  Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. , 1989, The Journal of allergy and clinical immunology.

[7]  C. Miller,et al.  Gammalinolenic acid-enriched diet alters cutaneous eicosanoids. , 1988, Biochemical and biophysical research communications.

[8]  C. Miller,et al.  Ability of 15-hydroxyeicosatrienoic acid (15-OH-20:3) to modulate macrophage arachidonic acid metabolism. , 1988, Biochemical and biophysical research communications.

[9]  C. Miller,et al.  Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products. , 1988, Prostaglandins.

[10]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[11]  D. Macdonald,et al.  Delayed-onset synergism between leukotriene B4 and prostaglandin E2 in human skin. , 1987, Prostaglandins.

[12]  J. Voorhees,et al.  Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation. , 1986, Journal of lipid research.

[13]  J. Ring,et al.  Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. , 1986, The Journal of investigative dermatology.

[14]  A. Kreft,et al.  Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages. , 1985, European journal of pharmacology.

[15]  M. Goldyne,et al.  Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. , 1984, The Journal of biological chemistry.

[16]  A. Black,et al.  The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. , 1984, The Journal of investigative dermatology.

[17]  P. Woollard,et al.  Production of intraepidermal microabscesses by topical application of leukotriene B4. , 1984, The Journal of investigative dermatology.

[18]  M. Zanetti,et al.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[20]  K. Frank Austen,et al.  Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .

[21]  J. Burton,et al.  ORAL EVENING-PRIMROSE-SEED OIL IMPROVES ATOPIC ECZEMA , 1982, The Lancet.

[22]  D. Horrobin,et al.  TREATMENT OF ATOPIC ECZEMA WITH EVENING PRIMROSE OIL , 1981, The Lancet.

[23]  R. Egan,et al.  Prostaglandins, arachidonic acid, and inflammation. , 1980, Science.

[24]  M. A. Bray,et al.  Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes. , 1979, Prostaglandins.

[25]  F. Kuehl,et al.  Macrophages synthesise and release prostaglandins in response to inflammatory stimuli , 1977, Nature.

[26]  K. Kragballe,et al.  In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils , 2004, Archives of Dermatological Research.

[27]  C. Miller,et al.  Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. , 1991, The Journal of investigative dermatology.

[28]  V. Ziboh,et al.  Metabolism and function of skin lipids. , 1988, Progress in lipid research.

[29]  P. Ward,et al.  Suppression of chronic inflammation by evening primrose oil. , 1981, Progress in lipid research.